THE DOSES OF POST-TRANSPLANTATION CYCLOPHOSPHAMIDE IN HAPLOIDENTICAL STEM CELL ALLOGRAFTS CAN BE REDUCED

被引：0
|
作者：
Carlos Olivares-Gazca, Juan [1 ]
de Lourdes Pastelin-Martinez, Maria [1 ,2 ]
Abigail Montes-Robles, Merittzel [1 ,2 ]
Manuel Gallardo-Perez, Moises [1 ]
Jared Hernandez-Flores, Edgar [1 ,3 ]
Robles-Nasta, Max [1 ,3 ]
Sanchez-Bonilla, Daniela [1 ]
Homero Gutierrez-Aguirre, Cesar [4 ]
Gomez-De-Leon, Andres [4 ]
Gomez-Almaguer, David [4 ]
Jose Ruiz-Delgado, Guillermo [1 ,3 ]
Jose Ruiz-Arguelles, Guillermo [1 ,3 ]
机构：
[1] Clin Ruiz, Centro Hematol & Med Interna, Puebla, Mexico
[2] Univ Anahuac Puebla, Puebla, Mexico
[3] Univ Popular Autonoma Estado Puebla, Puebla, Mexico
[4] Hosp Univ Dr Jose Eleuterio Gonzalez, Serv Hematol, Monterrey, Mexico
来源：
BONE MARROW TRANSPLANTATION | 2024年 / 59卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
P331
引用
收藏
页码：374 / 374
页数：1
相关论文
共 50 条
  • [41] Haploidentical Hematopoietic Stem Cell Transplantation with Post-Transplantation Cyclophosphamide in Children with High-Risk Leukemia Using a Reduced-Intensity Conditioning Regimen and Peripheral Blood as the Stem Cell Source
    Maria Trujillo, Angela
    Karduss, Amado J.
    Suarez, Gloria
    Perez, Rosendo
    Ruiz, Giovanni
    Cardona, Angelica
    Ramirez, Monica
    Betancur, Jose
    TRANSPLANTATION AND CELLULAR THERAPY, 2021, 27 (05): : 427.e1 - 427.e7
  • [42] Reduced Post-Transplant Cyclophosphamide Doses in T-Cell Replete Haploidentical Hematopoietic Stem Cell Transplantation in Elderly Patients with Hematologic Malignancies
    Dulery, Remy
    Goudet, Claire
    Bianchessi, Antonio
    Granata, Angela
    Harbi, Samia
    Maisano, Valerio
    Chabannon, Christian
    Malard, Florent
    Brissot, Eolia
    Sestili, Simona
    Mediavilla, Clemence
    Banet, Anne
    Van de Wyngaert, Zoe
    Paviglianiti, Annalisa
    Belhocine, Ramdane
    Ederhy, Stephane
    Pagliardini, Thomas
    Legrand, Faezeh
    Castagna, Lucas
    Blaise, Didier
    Mohty, Mohamad
    Furst, Sabine
    Devillier, Raynier
    BONE MARROW TRANSPLANTATION, 2020, 55 (SUPPL 1) : 138 - 139
  • [43] Reduced Dose of Post-Transplant Cyclophosphamide for HLA Haploidentical Peripheral Blood Stem Cell Transplantation
    Morishige, Satoshi
    Yamasaki, Yoshitaka
    Oya, Shuki
    Nakamura, Takayuki
    Ymaguchi, Maki
    Aoyama, Kazutoshi
    Seki, Ritsuko
    Mouri, Fumihiko
    Osaki, Koichi
    Nagafuji, Koji
    BLOOD, 2018, 132
  • [44] Early Post-Transplantation Serum Ferritin Level Predicts Survival in Recipients of Haploidentical Stem Cell Transplantation Using Post-Transplantation Cyclophosphamide as Graft-versus-Host Disease Prophylaxis
    Jullien, Maxime
    Orvain, Corentin
    Berceanu, Ana
    Couturier, Marie-Anne
    Guillaume, Thierry
    Peterlin, Pierre
    Garnier, Alice
    Le Bourgeois, Amandine
    Klemencie, Marion
    Schmidt, Aline
    Hunault, Mathilde
    Daguindau, Etienne
    Roussel, Xavier
    Delepine, Pascal
    Guillerm, Gaelle
    Giltat, Aurelien
    Francois, Sylvie
    Thepot, Sylvain
    Le Gouill, Steven
    Bene, Marie-C
    Chevallier, Patrice
    TRANSPLANTATION AND CELLULAR THERAPY, 2021, 27 (10): : 861.e1 - 861.e7
  • [45] Impact of Donor Age in Haploidentical-Post-Transplantation Cyclophosphamide versus Matched Unrelated Donor Post-Transplantation Cyclophosphamide Hematopoietic Stem Cell Transplantation in Patients with Acute Myeloid Leukemia
    Mehta, Rohtesh S.
    Ramdial, Jeremy
    Marin, David
    Alousi, Amin
    Kanakry, Christopher G.
    Champlin, Richard E.
    Rezvani, Katayoun
    Shpall, Elizabeth J.
    Page, Kristin
    Gadalla, Shahinaz M.
    Kebriaei, Partow
    Weisdorf, Daniel
    TRANSPLANTATION AND CELLULAR THERAPY, 2023, 29 (06): : 377.e1 - 377.e7
  • [46] Bone Marrow versus Peripheral Blood Grafts for Haploidentical Hematopoietic Cell Transplantation with Post-Transplantation Cyclophosphamide
    Mehta, Rohtesh S.
    Saliba, Rima M.
    Alsfeld, Leonard C.
    Jorgensen, Jeffrey L.
    Wang, Sa A.
    Anderlini, Paolo
    Al-Atrash, Gheath
    Bashir, Qaiser
    Ciurea, Stefan O.
    Hosing, Chitra M.
    Im, Jin S.
    Kebriaei, Partow
    Khouri, Issa
    Marin, David
    Nieto, Yago
    Olson, Amanda
    Oran, Betul
    Popat, Uday R.
    Qazilbash, Muzaffar H.
    Ramdial, Jeremy
    Rondon, Gabriela
    Saini, Neeraj
    Srour, Samer A.
    Rezvani, Katayoun
    Shpall, Elizabeth J.
    Champlin, Richard E.
    Alousi, Amin M.
    TRANSPLANTATION AND CELLULAR THERAPY, 2021, 27 (12): : 1003.e1 - 1003.e13
  • [47] Is Haploidentical Hematopoietic Cell Transplantation Using Post-Transplantation Cyclophosphamide Feasible in Sub-Saharan Africa?
    du Toit, Justin Rudolph
    Mcdonald, Andrew
    Brittain, David
    Cass, Michael
    Thomson, Jacqueline
    Oosthuizen, Jenna
    du Toit, Cecile
    Seftel, Matthew
    Louw, Vernon Johan
    Verburgh, Estelle
    TRANSPLANTATION AND CELLULAR THERAPY, 2021, 27 (12): : 1002.e1 - 1002.e8
  • [48] Haploidentical transplantation in children with unmanipulated peripheral blood stem cell graft: The need to look beyond post-transplantation cyclophosphamide in younger children
    Jaiswal, Sarita Rani
    Chakrabarti, Aditi
    Chatterjee, Sumita
    Ray, Kunal
    Chakrabarti, Suparno
    PEDIATRIC TRANSPLANTATION, 2016, 20 (05) : 675 - 682
  • [49] Haploidentical Stem Cell Transplantation With Post-Transplantation Cyclophosphamide for Aggressive Lymphomas: How Far Have We Come and Where Are We Going?
    Patel, Dilan A.
    WORLD JOURNAL OF ONCOLOGY, 2019, 10 (01) : 1 - 9
  • [50] Is Haploidentical Haematopoietic Stem Cell Transplantation (Haplo Sct) Using Post-Transplantation Cyclophosphamide (PTCY) Feasible in Sub-Saharan Africa?
    du Toit, Justin
    Mcdonald, Andrew
    Brittain, David
    Thomson, Jackie
    Oosthuizen, Jenna
    du Toit, Cecile
    Seftel, Matthew
    Verburgh, Estelle
    BONE MARROW TRANSPLANTATION, 2021, 56 (SUPPL 1) : 244 - 245
12345